IRWD Q3'26 Earnings: EPS estimate is 0.32 USD

What happened

Ironwood Pharmaceuticals is set to announce its Q3'26 results on October 29, with disclosure expected at 8:00 AM ET. Analysts estimate revenue of 119.99 million USD and earnings per share of 0.32 USD for the quarter.

Confirmed

Global impact / market context

Earnings per share is the profit attributed to each share, so the 0.32 USD estimate gives investors a simple gauge of expected profitability. Revenue near 119.99 million USD shows the sales scale analysts expect, helping investors judge whether the company's core business is growing.

Analyst inference

The supplied table shows past results sometimes beat or missed estimates, including a large prior revenue surprise. That history means the upcoming report may be compared against expectations rather than past numbers alone, which can shape how investors assess the company's performance trend.

Analyst inference

What to watch

1. Ironwood plans to release Q3'26 results on October 29 at 8:00 AM ET, so the exact figures will replace current estimates. Confirmed
2. Watch whether reported revenue lands above or below the 119.99 million USD estimate, since that gap can signal demand strength or weakness. Analyst inference
3. Watch whether actual earnings per share beat or miss the 0.32 USD estimate, because profit per share directly affects how investors value the stock. Analyst inference

Evidence

• Original source link unavailable